Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma

Glioblastoma is the most common and aggressive primary brain tumor in adults. New drug design and development is still a major challenge for glioma treatment. Increasing evidence has shown that nitazoxanide, an antiprotozoal drug, has a novel antitumor role in various tumors and exhibits multiple mo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cell Death Dis
Auteurs principaux: Wang, Xiaoxiong, Shen, Chen, Liu, Zhendong, Peng, Fei, Chen, Xin, Yang, Guang, Zhang, Daming, Yin, Zhiqin, Ma, Jichao, Zheng, Zhixing, Zhao, Boxian, Liu, Huailei, Wang, Ligang, Wu, Jianing, Han, Dayong, Wang, Kaikai, Zhong, Chen, Hou, Xu, Zhao, Wenyang, Shu, Mengting, Wang, Xinzhuang, Zhao, Shiguang
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177448/
https://ncbi.nlm.nih.gov/pubmed/30302016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-1058-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires